Movement Alert｜Hansoh Pharmaceutical Falls 3.03% in Regular Trading, Pharmaceutical Sector Under Broad Selling Pressure

Market Focus06-30 11:01

On June 30, Hansoh Pharmaceutical fell 3.03% in regular trading, trading at HKD 29.4/share, with turnover of approximately HKD 93.81 million. The decline came amid broad-based weakness across the pharmaceutical sector.

Among sector peers, CSPC Pharma fell 1.82%, Luye Pharma fell 6.38%, Hengrui Pharma fell 2.15%, SBP Group fell 2.0%, and Asymchem fell 5.42%. The pullback follows a strong session on June 29, when Hansoh Pharmaceutical surged 4.88% driven by concentrated pipeline catalysts and sector-wide strength. The company has recently seen multiple positive developments including NDA acceptance for its ADC drug with potential deal value exceeding USD 1.5 billion, shareholder approval of a share buyback authorization of up to 10%, and NDA filings for HS-10568 injection and weight-loss drug olatorepatide injection, accelerating its innovation pipeline commercialization.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107843829?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 11:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107843829","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Hansoh Pharmaceutical Falls 3.03% in Regular Trading, Pharmaceutical Sector Under Broad Selling Pressure","media":"Market Focus","content":"<p><p>On June 30, Hansoh Pharmaceutical fell 3.03% in regular trading, trading at HKD 29.4/share, with turnover of approximately HKD 93.81 million. The decline came amid broad-based weakness across the pharmaceutical sector.</p><p>Among sector peers, CSPC Pharma fell 1.82%, Luye Pharma fell 6.38%, Hengrui Pharma fell 2.15%, SBP Group fell 2.0%, and Asymchem fell 5.42%. The pullback follows a strong session on June 29, when Hansoh Pharmaceutical surged 4.88% driven by concentrated pipeline catalysts and sector-wide strength. The company has recently seen multiple positive developments including NDA acceptance for its ADC drug with potential deal value exceeding USD 1.5 billion, shareholder approval of a share buyback authorization of up to 10%, and NDA filings for HS-10568 injection and weight-loss drug olatorepatide injection, accelerating its innovation pipeline commercialization.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Hansoh Pharmaceutical Falls 3.03% in Regular Trading, Pharmaceutical Sector Under Broad Selling Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Hansoh Pharmaceutical Falls 3.03% in Regular Trading, Pharmaceutical Sector Under Broad Selling Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-30 11:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 30, Hansoh Pharmaceutical fell 3.03% in regular trading, trading at HKD 29.4/share, with turnover of approximately HKD 93.81 million. The decline came amid broad-based weakness across the pharmaceutical sector.</p><p>Among sector peers, CSPC Pharma fell 1.82%, Luye Pharma fell 6.38%, Hengrui Pharma fell 2.15%, SBP Group fell 2.0%, and Asymchem fell 5.42%. The pullback follows a strong session on June 29, when Hansoh Pharmaceutical surged 4.88% driven by concentrated pipeline catalysts and sector-wide strength. The company has recently seen multiple positive developments including NDA acceptance for its ADC drug with potential deal value exceeding USD 1.5 billion, shareholder approval of a share buyback authorization of up to 10%, and NDA filings for HS-10568 injection and weight-loss drug olatorepatide injection, accelerating its innovation pipeline commercialization.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03692","symbol_name":"翰森制药","start_time":0,"source_url":"","article_id":"1107843829","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107843829","pubTimestamp":1782788513,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 30, Hansoh Pharmaceutical fell 3.03% in regular trading, trading at HKD 29.4/share, with turnover of approximately HKD 93.81 million. The decline came amid broad-based weakness across the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03692":"翰森制药"},"translate_title":"异动快讯|豪森药业常规交易跌3.03%医药板块遭广泛抛压","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":1},"content_text":"On June 30, Hansoh Pharmaceutical fell 3.03% in regular trading, trading at HKD 29.4/share, with turnover of approximately HKD 93.81 million. The decline came amid broad-based weakness across the pharmaceutical sector.Among sector peers, CSPC Pharma fell 1.82%, Luye Pharma fell 6.38%, Hengrui Pharma fell 2.15%, SBP Group fell 2.0%, and Asymchem fell 5.42%. The pullback follows a strong session on June 29, when Hansoh Pharmaceutical surged 4.88% driven by concentrated pipeline catalysts and sector-wide strength. The company has recently seen multiple positive developments including NDA acceptance for its ADC drug with potential deal value exceeding USD 1.5 billion, shareholder approval of a share buyback authorization of up to 10%, and NDA filings for HS-10568 injection and weight-loss drug olatorepatide injection, accelerating its innovation pipeline commercialization.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107843829","isCrawlerRequest":true}